Sentence,Label
"In a variety of bacterial species, including Mycobacterium tuberculosis, MODIFICATION of [E]PROTEIN[/E] has emerged as the mode of action of a toxin-antitoxin system named DarTG, with the resultant products perceived as DNA damage by the cell",1
"In a variety of bacterial species, including Mycobacterium tuberculosis, MODIFICATION of thymidine has emerged as the mode of action of a toxin-antitoxin system named [E]PROTEIN[/E], with the resultant products perceived as DNA damage by the cell",0
"[E]PROTEIN[/E] (PARP1, also known as ADPRT1) is a multifunctional human TRANSFERASE",0
"Poly(ADP-ribose) polymerase 1 ([E]PROTEIN[/E], also known as ADPRT1) is a multifunctional human TRANSFERASE",0
"Poly(ADP-ribose) polymerase 1 (PARP1, also known as [E]PROTEIN[/E]) is a multifunctional human TRANSFERASE",0
"For instance, [E]PROTEIN[/E] catalyzes MODIFICATION of arginine residues in Trim72, a protein specifically expressed in muscle cells and involved in cell membrane repair, which is enhanced upon its MODIFICATION",0
"For instance, ADP-ribosyltransferase 1 (ART1) catalyzes MODIFICATION of [E]PROTEIN[/E] in Trim72, a protein specifically expressed in muscle cells and involved in cell membrane repair, which is enhanced upon its MODIFICATION",1
"For instance, ADP-ribosyltransferase 1 (ART1) catalyzes MODIFICATION of arginine residues in [E]PROTEIN[/E], a protein specifically expressed in muscle cells and involved in cell membrane repair, which is enhanced upon its MODIFICATION",1
"For instance, ADP-ribosyltransferase 1 (ART1) catalyzes MODIFICATION of arginine residues in Trim72, a protein specifically expressed in muscle cells and involved in cell membrane repair, which is enhanced upon [E]PROTEIN[/E] MODIFICATION",1
"[E]PROTEIN[/E] are MODIFIED by TRANSFERASE diphtheria toxin-like 1 at specific amino acid residues, in particular lysines, of the histones tails",1
"Histones are MODIFIED by TRANSFERASE [E]PROTEIN[/E] at specific amino acid residues, in particular lysines, of the histones tails",0
"Histones are MODIFIED by TRANSFERASE diphtheria toxin-like 1 at [E]PROTEIN[/E], in particular lysines, of the histones tails",1
"Histones are MODIFIED by TRANSFERASE diphtheria toxin-like 1 at specific amino acid residues, in particular [E]PROTEIN[/E], of the histones tails",1
"Histones are MODIFIED by TRANSFERASE diphtheria toxin-like 1 at specific amino acid residues, in particular lysines, of the [E]PROTEIN[/E]",1
"Thus, [E]PROTEIN[/E] MODIFICATION may be considered an additional component of the histone code",1
"Thus, histone MODIFICATION may be considered an additional component of the [E]PROTEIN[/E] code",0
The [E]PROTEIN[/E] of p53 orchestrates the interplay between non-covalent and covalent MODIFICATION of p53 by PARP1,0
The C-terminal domain of [E]PROTEIN[/E] orchestrates the interplay between non-covalent and covalent MODIFICATION of p53 by PARP1,0
The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent MODIFICATION of [E]PROTEIN[/E] by PARP1,1
The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent MODIFICATION of p53 by [E]PROTEIN[/E],0
"[E]PROTEIN[/E], the best characterized of the 17-member PARP family, is considered a key isoform responsible for MODIFICATION of several nuclear proteins",0
"PARP-1, the best characterized of the 17-member [E]PROTEIN[/E] family, is considered a key isoform responsible for MODIFICATION of several nuclear proteins",0
"PARP-1, the best characterized of the 17-member PARP family, is considered a key isoform responsible for MODIFICATION of [E]PROTEIN[/E]",1
"Interestingly, [E]PROTEIN[/E] is MODIFIED by PARP10 and the MARylation of PLK1 significantly inhibits its kinase activity and oncogenic function in HCC",1
"Interestingly, PLK1 is MODIFIED by [E]PROTEIN[/E] and the MARylation of PLK1 significantly inhibits its kinase activity and oncogenic function in HCC",0
"Interestingly, PLK1 is MODIFIED by PARP10 and the MARylation of [E]PROTEIN[/E] significantly inhibits its kinase activity and oncogenic function in HCC",0
The founding member of mono-TRANSFERASES is [E]PROTEIN[/E]/PARP10,0
The founding member of mono-TRANSFERASES is ARTD10/[E]PROTEIN[/E],0
"Loss of [E]PROTEIN[/E] prevented MODIFICATION of eEF2, rendered cells resistant to PE and DT, but does not affect sensitivity toward other protein synthesis inhibitors, such as saporin or cycloheximide",0
"Loss of diphthamide prevented MODIFICATION of [E]PROTEIN[/E], rendered cells resistant to PE and DT, but does not affect sensitivity toward other protein synthesis inhibitors, such as saporin or cycloheximide",1
"Loss of diphthamide prevented MODIFICATION of eEF2, rendered cells resistant to PE and DT, but does not affect sensitivity toward other [E]PROTEIN[/E], such as saporin or cycloheximide",0
"Loss of diphthamide prevented MODIFICATION of eEF2, rendered cells resistant to PE and DT, but does not affect sensitivity toward other protein synthesis inhibitors, such as [E]PROTEIN[/E] or cycloheximide",0
"Loss of diphthamide prevented MODIFICATION of eEF2, rendered cells resistant to PE and DT, but does not affect sensitivity toward other protein synthesis inhibitors, such as saporin or [E]PROTEIN[/E]",0
MODIFICATION of [E]PROTEIN[/E] and NF-_B Transcription Factors Modulate Macrophage Inflammatory Gene Expression in LPS-Induced Acute Lung Injury,1
MODIFICATION of NFATc3 and [E]PROTEIN[/E] Modulate Macrophage Inflammatory Gene Expression in LPS-Induced Acute Lung Injury,1
MODIFICATION of NFATc3 and NF-_B Transcription Factors Modulate Macrophage Inflammatory Gene Expression in [E]PROTEIN[/E]-Induced Acute Lung Injury,0
"Thus, our study demonstrates that inhibiting [E]PROTEIN[/E] and NF-_B MODIFICATION with PARP-1 inhibitors prevented LPS-induced ALI pathogenesis",1
"Thus, our study demonstrates that inhibiting NFATc3 and [E]PROTEIN[/E] MODIFICATION with PARP-1 inhibitors prevented LPS-induced ALI pathogenesis",1
"Thus, our study demonstrates that inhibiting NFATc3 and NF-_B MODIFICATION with [E]PROTEIN[/E] prevented LPS-induced ALI pathogenesis",0
"On the other hand, [E]PROTEIN[/E] activation results in inhibition of GAPDH by MODIFICATION",0
"On the other hand, PARP activation results in inhibition of [E]PROTEIN[/E] by MODIFICATION",1
Nitric oxide stimulates the auto-MODIFICATION of [E]PROTEIN[/E] in a time and concentration-dependent manner with maximal effects after about 60 min,1
"TRANSFERASE activation in turn depletes the intracellular concentration of its substrate NAD(+), slowing the rate of glycolysis, electron transport, and ATP formation, and produces an MODIFICATION of the [E]PROTEIN[/E]",1
"In hESCs, [E]PROTEIN[/E] exists in multisubunit protein complexes and can be MODIFIED",1
Targeting of [E]PROTEIN[/E] to the nucleolus inhibits nucleolar transcription through a MODIFICATION-dependent mechanism,1
"Here, [E]PROTEIN[/E] MODIFIES G-actin, resulting in depolymerization of the actin cytoskeleton",0
"Here, CDTa MODIFIES [E]PROTEIN[/E], resulting in depolymerization of the actin cytoskeleton",1
"Here, CDTa MODIFIES G-actin, resulting in depolymerization of the [E]PROTEIN[/E] cytoskeleton",0
"Vibrio [E]PROTEIN[/E] is a cytotoxin that MODIFIES eukaryotic elongation factor 2, inhibiting protein synthesis, and inducing apoptosis",0
"Vibrio cholerae produced-Cholix toxin (Cholix) is a [E]PROTEIN[/E] that MODIFIES eukaryotic elongation factor 2, inhibiting protein synthesis, and inducing apoptosis",0
"Vibrio cholerae produced-Cholix toxin (Cholix) is a cytotoxin that MODIFIES [E]PROTEIN[/E], inhibiting protein synthesis, and inducing apoptosis",1
Here we demonstrate that [E]PROTEIN[/E] localizes to the Golgi apparatus and is MODIFIED by tankyrase-1 during late G2 and prophase,1
Here we demonstrate that Miki localizes to the Golgi apparatus and is MODIFIED by [E]PROTEIN[/E] during late G2 and prophase,0
[E]PROTEIN[/E] MODIFICATION inhibits translation and maintains proteostasis in cancers,1
"Moreover, we demonstrate that the closely related hydrolytically active macrodomain of [E]PROTEIN[/E], Mac1, efficiently reverses PARP14 MODIFICATION in vitro and in cells, supporting the evolution of viral macrodomains to counteract PARP14-mediated antiviral response",0
"Moreover, we demonstrate that the closely related hydrolytically active macrodomain of SARS2 Nsp3, [E]PROTEIN[/E], efficiently reverses PARP14 MODIFICATION in vitro and in cells, supporting the evolution of viral macrodomains to counteract PARP14-mediated antiviral response",0
"Moreover, we demonstrate that the closely related hydrolytically active macrodomain of SARS2 Nsp3, Mac1, efficiently reverses [E]PROTEIN[/E] MODIFICATION in vitro and in cells, supporting the evolution of viral macrodomains to counteract PARP14-mediated antiviral response",1
"Moreover, we demonstrate that the closely related hydrolytically active macrodomain of SARS2 Nsp3, Mac1, efficiently reverses PARP14 MODIFICATION in vitro and in cells, supporting the evolution of viral macrodomains to counteract [E]PROTEIN[/E]-mediated antiviral response",0
"In addition to Arh1-KO mice showed increased MODIFICATION of [E]PROTEIN[/E], a membrane-repair protein",1
"In vitro, P2X7R+ CD8 T cells were susceptible to [E]PROTEIN[/E]-mediated MODIFICATION and NICD, which was exacerbated upon blockade of the NAD+-degrading TRANSFERASE CD38",0
"In vitro, P2X7R+ CD8 T cells were susceptible to ART1-mediated MODIFICATION and NICD, which was exacerbated upon blockade of the NAD+-degrading TRANSFERASE [E]PROTEIN[/E]",0
"[E]PROTEIN[/E] can reverse the MODIFICATION of host proteins, and inhibit the cascade immune response with IFN as the core, thereby promoting the intracellular replication of SARS-CoV-2",0
"NSP3 macrodomain can reverse the MODIFICATION of [E]PROTEIN[/E], and inhibit the cascade immune response with IFN as the core, thereby promoting the intracellular replication of SARS-CoV-2",1
"NSP3 macrodomain can reverse the MODIFICATION of host proteins, and inhibit the cascade immune response with [E]PROTEIN[/E] as the core, thereby promoting the intracellular replication of SARS-CoV-2",0
"While [E]PROTEIN[/E]/PARP1-mediated MODIFICATION has extensively been studied in the past 60 years, comparably little is known about the physiological function of MODIFICATION and the enzymes involved in its turnover",0
"While ARTD1/[E]PROTEIN[/E]-mediated MODIFICATION has extensively been studied in the past 60 years, comparably little is known about the physiological function of MODIFICATION and the enzymes involved in its turnover",0
"[E]PROTEIN[/E] and DNA can be MODIFIED by specific TRANSFERASE such as PARP1-3, PARP10 and tRNA 2'-phosphotransferase (TRPT1)",1
"RNA and [E]PROTEIN[/E] can be MODIFIED by specific TRANSFERASE such as PARP1-3, PARP10 and tRNA 2'-phosphotransferase (TRPT1)",1
"RNA and DNA can be MODIFIED by specific TRANSFERASE such as [E]PROTEIN[/E], PARP10 and tRNA 2'-phosphotransferase (TRPT1)",0
"RNA and DNA can be MODIFIED by specific TRANSFERASE such as PARP1-3, [E]PROTEIN[/E] and tRNA 2'-phosphotransferase (TRPT1)",0
"RNA and DNA can be MODIFIED by specific TRANSFERASE such as PARP1-3, PARP10 and [E]PROTEIN[/E]",0
[E]PROTEIN[/E] protects against toxic DNA MODIFICATION,0
TARG1 protects against toxic [E]PROTEIN[/E] MODIFICATION,1
[E]PROTEIN[/E]-mediated VAPB MODIFICATION regulates calcium homeostasis,0
ARTC1-mediated [E]PROTEIN[/E] MODIFICATION regulates calcium homeostasis,1